e-learning
resources
ERJ
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Novel drugs against tuberculosis: a clinician's perspective
Olaru Ioana Diana, von Groote-Bidlingmaier Florian, Heyckendorf Jan, Yew Wing Wai, Lange Christoph, Chang Kwok Chiu
Source:
Eur Respir J 2015; 45: 1119-1131
Journal Issue:
April
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Olaru Ioana Diana, von Groote-Bidlingmaier Florian, Heyckendorf Jan, Yew Wing Wai, Lange Christoph, Chang Kwok Chiu. Novel drugs against tuberculosis: a clinician's perspective. Eur Respir J 2015; 45: 1119-1131
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
Source: Eur Respir J 2013; 42: 1449-1453
Year: 2013
Tuberculosis elimination, patients' lives and rational use of new drugs: revisited
Source: Eur Respir J 2016; 47: 664-667
Year: 2016
Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities
Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020
Year: 2021
Living with the challenges of treating tuberculosis: The patient and healthcare professional perspective
Source: Breathe 2015; 11:71-72
Year: 2015
What's new in the management of CAP?
Source: Annual Congress 2012 - New guidelines in respiratory infections
Year: 2012
Atypical mycobacteriosis : new drugs, new strategies
Source: Annual Congress 2004 - PG11 - Multiresistant tuberculosis and atypical mycobacterial disease
Year: 2004
Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance
Source: Eur Respir J 2012; 39: 802-804
Year: 2012
Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
Source: Eur Respir Rev, 28 (152) 190035; 10.1183/16000617.0035-2019
Year: 2019
MDR-TB management: what is new?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
What's new in sarcoidosis management?
Source: Annual Congress 2013 –ME5 What's new in sarcoidosis management?
Year: 2013
Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe?
Source: Eur Respir J 2016; 48: 1230-1233
Year: 2016
Towards the elimination of tuberculosis: challenges ahead from a European perspective
Source: Annual Congress 2012 - Joint session with WHO and ECDC "Towards elimination of tuberculosis"
Year: 2012
Escaping the Plato's cave of latent tuberculosis testing: a path for developers of predictive tests for risk of tuberculosis
Source: Eur Respir J, 52 (4) 1801616; 10.1183/13993003.01616-2018
Year: 2018
Biomarker development in asthma from a patient's perspective
Source: Breathe, 15 (4) 277; 10.1183/20734735.0303-2019
Year: 2019
Moving tuberculosis vaccines from theory to practice
Source: International Congress 2019 – Vaccines against respiratory infections
Year: 2019
Enhancing patient safety: New WHO guidance on pharmacovigilance in tuberculosis care
Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features
Year: 2012
Key patients' needs: a patient's perspective
Source: Eur Respir Monogr 2016; 71: 243-252
Year: 2016
125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is science enough to tackle the epidemic?
Source: Eur Respir J 2007; 29: 423-427
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept